These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2268322)
1. Introduction of a non-native disulfide bridge to human lysozyme by cysteine scanning mutagenesis. Kanaya E; Kanaya S; Kikuchi M Biochem Biophys Res Commun; 1990 Dec; 173(3):1194-9. PubMed ID: 2268322 [TBL] [Abstract][Full Text] [Related]
2. Enthalpic destabilization of a mutant human lysozyme lacking a disulfide bridge between cysteine-77 and cysteine-95. Kuroki R; Inaka K; Taniyama Y; Kidokoro S; Matsushima M; Kikuchi M; Yutani K Biochemistry; 1992 Sep; 31(35):8323-8. PubMed ID: 1525170 [TBL] [Abstract][Full Text] [Related]
3. Structure of a stabilizing disulfide bridge mutant that closes the active-site cleft of T4 lysozyme. Jacobson RH; Matsumura M; Faber HR; Matthews BW Protein Sci; 1992 Jan; 1(1):46-57. PubMed ID: 1304882 [TBL] [Abstract][Full Text] [Related]
4. Effect of an alternative disulfide bond on the structure, stability, and folding of human lysozyme. Arai M; Hamel P; Kanaya E; Inaka K; Miki K; Kikuchi M; Kuwajima K Biochemistry; 2000 Mar; 39(12):3472-9. PubMed ID: 10727242 [TBL] [Abstract][Full Text] [Related]
5. Folding mechanism of mutant human lysozyme C77/95A with increased secretion efficiency in yeast. Taniyama Y; Ogasahara K; Yutani K; Kikuchi M J Biol Chem; 1992 Mar; 267(7):4619-24. PubMed ID: 1537844 [TBL] [Abstract][Full Text] [Related]
6. The crystal structure of a mutant human lysozyme C77/95A with increased secretion efficiency in yeast. Inaka K; Taniyama Y; Kikuchi M; Morikawa K; Matsushima M J Biol Chem; 1991 Jul; 266(19):12599-603. PubMed ID: 2061330 [TBL] [Abstract][Full Text] [Related]
7. Folding of human lysozyme in vivo by the formation of an alternative disulfide bond. Kanaya E; Kikuchi M J Biol Chem; 1992 Jul; 267(21):15111-5. PubMed ID: 1634546 [TBL] [Abstract][Full Text] [Related]
8. Contribution of a hydrogen bond to the thermal stability of the mutant human lysozyme C77/95S. Yamada H; Kanaya E; Ueno Y; Ikehara M; Nakamura H; Kikuchi M Biol Pharm Bull; 1994 May; 17(5):612-6. PubMed ID: 7920418 [TBL] [Abstract][Full Text] [Related]
9. Kinetic consequences of the removal of a disulfide bridge on the folding of hen lysozyme. Eyles SJ; Radford SE; Robinson CV; Dobson CM Biochemistry; 1994 Nov; 33(44):13038-48. PubMed ID: 7947709 [TBL] [Abstract][Full Text] [Related]
10. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme. Yamada T; Uyeda A; Kidera A; Kikuchi M Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of a mutant human lysozyme with a substituted disulfide bond. Inaka K; Kanaya E; Kikuchi M; Miki K Proteins; 2001 Jun; 43(4):413-9. PubMed ID: 11340658 [TBL] [Abstract][Full Text] [Related]
12. Evidence for intramolecular disulfide bond shuffling in the folding of mutant human lysozyme. Taniyama Y; Kuroki R; Omura F; Seko C; Kikuchi M J Biol Chem; 1991 Apr; 266(10):6456-61. PubMed ID: 2007594 [TBL] [Abstract][Full Text] [Related]
13. Evidence for difference in the roles of two cysteine residues involved in disulfide bond formation in the folding of human lysozyme. Taniyama Y; Yamamoto Y; Kuroki R; Kikuchi M J Biol Chem; 1990 May; 265(13):7570-5. PubMed ID: 2110167 [TBL] [Abstract][Full Text] [Related]
14. Native-like tertiary structure formation in the alpha-domain of a hen lysozyme two-disulfide variant. Tachibana H; Oka T; Akasaka K J Mol Biol; 2001 Nov; 314(2):311-20. PubMed ID: 11718564 [TBL] [Abstract][Full Text] [Related]
15. The transition state in the folding-unfolding reaction of four species of three-disulfide variant of hen lysozyme: the role of each disulfide bridge. Yokota A; Izutani K; Takai M; Kubo Y; Noda Y; Koumoto Y; Tachibana H; Segawa S J Mol Biol; 2000 Feb; 295(5):1275-88. PubMed ID: 10653703 [TBL] [Abstract][Full Text] [Related]
16. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor. Liu Y; Breslauer K; Anderson S Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the early stage of the folding process of reduced lysozyme using all lysozyme variants containing a pair of cysteines. Shioi S; Imoto T; Ueda T Biochemistry; 2004 May; 43(18):5488-93. PubMed ID: 15122914 [TBL] [Abstract][Full Text] [Related]
18. Effects of proline mutations on the unfolding and refolding of human lysozyme: the slow refolding kinetic phase does not result from proline cis-trans isomerization. Herning T; Yutani K; Taniyama Y; Kikuchi M Biochemistry; 1991 Oct; 30(41):9882-91. PubMed ID: 1911779 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of protein stabilization by disulfide bridges: calorimetric unfolding studies on disulfide-deficient mutants of the alpha-amylase inhibitor tendamistat. Vogl T; Brengelmann R; Hinz HJ; Scharf M; Lötzbeyer M; Engels JW J Mol Biol; 1995 Dec; 254(3):481-96. PubMed ID: 7490764 [TBL] [Abstract][Full Text] [Related]
20. Indication of possible post-translational formation of disulphide bonds in the beta-sheet domain of human lysozyme. Kanaya E; Ishihara K; Tsunasawa S; Nokihara K; Kikuchi M Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):469-76. PubMed ID: 8503881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]